Researchers at the Huntsman Cancer Institute have innovated a groundbreaking technology known as the Muse Magnetic Resonance-Guided Focused Ultrasound System, aiming to combat breast cancer tumors without resorting to surgery, as outlined in coverage by WINK News. This cutting-edge outpatient procedure integrates MRI technology to precisely locate breast tumors. Subsequently, a high-intensity focused ultrasound is directed with pinpoint accuracy to eliminate these tumors while safeguarding the integrity of surrounding healthy tissues and organs.
The process, which typically lasts a couple of hours, offers patients a noninvasive alternative devoid of extended recovery periods or the need for reconstructive surgery. Acknowledging the discomfort of prolonged MRI sessions, a specialized table has been devised specifically for use with Muse, enhancing patient comfort during the procedure.
This pioneering technique is currently undergoing rigorous evaluation in clinical trials. Researchers are optimistic that this novel technology could emerge as a promising treatment avenue for certain breast cancer patients within the coming years, potentially revolutionizing the approach to breast cancer care and management.
Leave feedback about this